As of 2025-12-22, the Intrinsic Value of Revolution Medicines Inc (RVMD) is -12.93 USD. This RVMD valuation is based on the model Peter Lynch Fair Value. With the current market price of 78.78 USD, the upside of Revolution Medicines Inc is -116.41%.
Based on its market price of 78.78 USD and our intrinsic valuation, Revolution Medicines Inc (RVMD) is overvalued by 116.41%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.93 - -12.93 | -12.93 | -116.41% |
| P/E | (27.97) - (53.36) | (45.89) | -158.2% |
| DDM - Stable | (17.27) - (69.38) | (43.33) | -155.0% |
| DDM - Multi | (3.43) - (10.99) | (5.25) | -106.7% |
| Market Cap (mil) | 15,229.75 |
| Beta | 1.00 |
| Outstanding shares (mil) | 193.32 |
| Enterprise Value (mil) | 15,268.82 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.91% |
| Cost of Debt | 5.00% |
| WACC | 7.95% |